Bristol-Myers Squibb (NY: BMY )

63.81 USD +0.23 (+0.36%)

Official Closing Price Updated: 7:59 PM EDT, Apr 14, 2021 Add to My Watchlist

Price and Volume

Volume	7,639,800
Open	63.75
Bid (Size)	63.93 (1)
Ask (Size)	64.01 (1)
Prev. Close	63.58
Today's Range	63.58 - 63.96
52wk Range	54.07 - 67.16
Shares Outstanding	N/A
Dividend Yield	3.07%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma

April 14, 2021

BMS Receives EC Approval for Opdivo® (nivolumab) in Comb w Cabometyx® (cabozantinib) as First-Line Treatment for Patients w Advanced Renal Cell Carcin

Pyramid Biosciences Announces Leadership Team Expansion

April 14, 2021

Pyramid Biosciences, Inc., a Boston-based, clinical-stage biotechnology company, today announced two new appointments to its leadership team.

Performance

YTD	+3.96%	+3.96%
1 Month	+3.94%	+3.94%
3 Month	-1.42%	-1.42%
6 Month	+4.61%	+4.61%
1 Year	+6.28%	+6.28%

More News

Evotec Launches 'BeLAB2122', Translating Academic Innovation from Leading German Life Science Region in Collaboration with Bristol Myers Squibb

April 13, 2021

Notable Wednesday Option Activity: BAC, GALT, BMY

April 14, 2021

Top Penny Stocks To Buy Now? 3 Analysts Expect Big Upside From These

April 11, 2021

Neoadjuvant Opdivo (nivolumab) Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial

April 10, 2021

Why This Bristol-Myers Squibb Stock Analyst Is Turning Bullish On The Pharma Company's Pipeline

April 13, 2021

CORRECTING and REPLACING Bristol Myers Squibb Announces Opdivo (nivolumab) plus Chemotherapy and Opdivo plus Yervoy (ipilimumab) Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unre

April 08, 2021

Follow Warren Buffett Into These 3 Pharma Companies

April 14, 2021

Alexandria Real Estate Equities Is My Favorite Office REIT

April 14, 2021

Here's a Multibillion-Dollar Market for Johnson & Johnson

April 13, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.